Crossref
The Significance of Procalcitonin and Biomarkers for Patients Who are Treated in Intensive Care Unit With COPD Diagnosis
Comprehensive Medicine · 2023
DOI: 10.14744/cm.2022.44946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comprehensive Medicine, 2023. Verfasst von Onur Sarban.
Themen: Intensivpflege, COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sarban, O. (2023). The Significance of Procalcitonin and Biomarkers for Patients Who are Treated in Intensive Care Unit With COPD Diagnosis. Comprehensive Medicine. https://doi.org/10.14744/cm.2022.44946
Vancouver
Sarban O. The Significance of Procalcitonin and Biomarkers for Patients Who are Treated in Intensive Care Unit With COPD Diagnosis. Comprehensive Medicine. 2023. doi:10.14744/cm.2022.44946
BibTeX
@article{Sarban2023,
author = {Sarban, Onur},
title = {The Significance of Procalcitonin and Biomarkers for Patients Who are Treated in Intensive Care Unit With COPD Diagnosis},
journal = {Comprehensive Medicine},
year = {2023},
doi = {10.14744/cm.2022.44946}
}
EUVIMED